Aptamer-Based Diagnostic Systems for the Rapid Screening of TB at the Point-of-Care
Open Access
- 28 July 2021
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 11 (8), 1352
- https://doi.org/10.3390/diagnostics11081352
Abstract
The transmission of Tuberculosis (TB) is very rapid and the burden it places on health care systems is felt globally. The effective management and prevention of this disease requires that it is detected early. Current TB diagnostic approaches, such as the culture, sputum smear, skin tuberculin, and molecular tests are time-consuming, and some are unaffordable for low-income countries. Rapid tests for disease biomarker detection are mostly based on immunological assays that use antibodies which are costly to produce, have low sensitivity and stability. Aptamers can replace antibodies in these diagnostic tests for the development of new rapid tests that are more cost effective; more stable at high temperatures and therefore have a better shelf life; do not have batch-to-batch variations, and thus more consistently bind to a specific target with similar or higher specificity and selectivity and are therefore more reliable. Advancements in TB research, in particular the application of proteomics to identify TB specific biomarkers, led to the identification of a number of biomarker proteins, that can be used to develop aptamer-based diagnostic assays able to screen individuals at the point-of-care (POC) more efficiently in resource-limited settings.This publication has 198 references indexed in Scilit:
- Emergence and Spread of Extensively and Totally Drug-Resistant Tuberculosis, South AfricaEmerging Infectious Diseases, 2013
- Novel system for detecting SARS coronavirus nucleocapsid protein using an ssDNA aptamerJournal of Bioscience and Bioengineering, 2011
- Mycolic acids as diagnostic markers for tuberculosis case detection in humans and drug efficacy in miceEMBO Molecular Medicine, 2011
- What are biomarkers?Current Opinion in HIV and AIDS, 2010
- Rapid Molecular Detection of Tuberculosis and Rifampin ResistanceThe New England Journal of Medicine, 2010
- Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?Nature Reviews Microbiology, 2010
- Dynamic antibody responses to the Mycobacterium tuberculosis proteomeProceedings of the National Academy of Sciences of the United States of America, 2010
- Breath biomarkers of active pulmonary tuberculosisTuberculosis, 2010
- Secreted transcription factor controls Mycobacterium tuberculosis virulenceNature, 2008
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998